News
-
OKRA joins Microsoft and Amazon in global venture
Cambridge AI company OKRA Technologies has joined global giants such as Microsoft and Amazon Web Services to put its expertise at the disposal of the... Read More
-
Qualcomm Technologies ace joins PROWLER.io
Cambridge-based PROWLER.io, a leader in artificial intelligence-powered decision-making, has appointed Gary Brotman as vice-president of Product... Read More
-
New managing partner at EY in Cambridge
EY has announced the promotion of Stuart Wilkinson to new office managing partner in Cambridge to lead the office and continue its growth in the East... Read More
-
Birketts boss Agar joins Hopkins board
Jonathan Agar, CEO at leading law firm Birketts, has joined the Hopkins Board as a non-executive director of the award-winning housebuilding company... Read More
-
KISS accelerates Cambridge growth roadmap
Cambridge creative agency, Kiss has continued to ramp up its team with a quartet of appointments. The agency says the latest recruitment drive is in... Read More
-
Cambridge biotech luminaries deliver masterclass on hiring and investment
Dr Jane Osbourn and Dr Andy Richards are two of the most prominent biotech names in the Cambridge life science cluster, writes Sarah Brereton. Dr... Read More
-
Next generation cell and gene therapies: fine tuning the promise
On 19 November, the UK BioBeat19 summit goes to Stevenage to discuss the potential of cell and gene therapy and how to accelerate these... Read More
-
Hotston Moore coup for JDC Group
The JDC Group has appointed celebrated accountant Fiona Hotston Moore as a director of Forensic and Advisory Services. JDC is an independent... Read More
-
Double landmark for Cambridge Cancer Genomics
Cambridge Cancer Genomics (CCG.ai) has made a significant addition to its top team. Senior translational oncology Fellow Dr Gianmarco Contino is a... Read More
-
Penningtons Manches Cooper strengthens life sciences team
The Cambridge office of top 50 law firm Penningtons Manches Cooper has added to its expertise in advising clients on IP and commercial issues with... Read More
-
Molecular diagnostics supernova on board at Congenica
One of the world’s most pre-eminent molecular diagnostics specialists has boosted the board of Cambridge digital health company Congenica. Dr... Read More
-
MacDonald-Clink joins Arecor top team
Cambridge biopharma company Arecor has made a key appointment as it bids to broaden and accelerate partnership deals. Jim MacDonald-Clink has been... Read More
-
Tap into your own DNA to make healthiest food choices
Cambridge brainpower is at the heart of world-first technology that helps consumers tap into their own DNA to make healthier food and drink choices... Read More
-
Cambridge startup hopes to raise £7.5m diabetes cash
Young Cambridge company ET-traps Limited is bidding to raise £7.5 million to accelerate its fight against diabetes. The money would allow ET-traps... Read More
-
Brilliant bounceback – and Sosei all of us!
Sosei Heptares, whose R & D engine room is at Granta Park, Cambridge, has enjoyed a phenomenal nine months to end-September after cashing in on... Read More
-
AVEVA shareholders fill their boots as stock soars
Cambridge industrial software business AVEVA handed shareholders an interim dividend spike of 10.7 per cent to 15.5p a share after a thumping set of... Read More
-
Smart labels deal hands PragmatIC another global edge
Cambridge-based PragmatIC, a world leader in ultra-low-cost flexible electronics, has again shown its eye for a market-leading growth opportunity... Read More
-
New Oxford-Cambridge Arc infrastructure could deliver over a million jobs by 2050
The Oxford-Cambridge Arc has the potential to create up to 1.1 million new jobs by 2050 if the required new infrastructure is delivered, according to... Read More
-
Stansted Airport expansion blueprint set to fly again
Stansted Airport owner MAG is confident that consent for major expansion – put on hold by a change in leadership at Uttlesford District Council in... Read More
-
Abcam swallows Expedeon brands in €120m cash deal
Cambridge life science power player Abcam is paying €120 million cash to acquire Expedeon’s Proteomics and Immunology business, expanding offerings... Read More